Influenza A+B/COVID-19/ RSV Antigen Rapid Test (UDI 6971771200859)
Manufactured by Hangzhou Lysun Biotechnology Co., Ltd
Device Regulatory Overview
The Influenza A+B/COVID-19/ RSV Antigen Rapid Test (Model/Catalog Number: Influenza A+B/ COVID-19/ RSV Antigen Rapid Test) is a medical device manufactured by Hangzhou Lysun Biotechnology Co., Ltd. This product is indexed under FDA Product Code / Category Classification W02010299 within international Unique Device Identification (UDI) compliance databases.
Technical Specifications
- Model Number
- Influenza A+B/ COVID-19/ RSV Antigen Rapid Test
- Product Code / EMDN
- W02010299
- Device Name
- Influenza A+B/ COVID-19/ RSV Antigen Rapid Test
- Database Sync Date
- 2026-08-09 16:29:11
Full Regulatory Attributes
🔒 Token Gated
{
"review_panel": "AN",
"gudid_di_status": "Published",
"sterilization_methods": ["EO", "Gamma"],
"rx_only": true
}
Unlock Compliance Data & Serialization Specs
Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.
Get API Token Access ($49/mo)Frequently Asked Questions
Who is the primary manufacturer of Influenza A+B/COVID-19/ RSV Antigen Rapid Test?
The registered manufacturer of record for Influenza A+B/COVID-19/ RSV Antigen Rapid Test is Hangzhou Lysun Biotechnology Co., Ltd.
What is the Primary UDI-DI identifier for Influenza A+B/COVID-19/ RSV Antigen Rapid Test?
The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 6971771200859.
What classification code is assigned to this device?
This device is registered under product classification code W02010299.
Similar Classification Devices (W02010299)
Other Devices by Hangzhou Lysun Biotechnology Co., Ltd
Programmatic Export
Export this master device record as standardized JSON or CSV for compliance audits.
JSON API Endpoint